Loading...
We have set up our new Discord server! Share your feedback and find like-minded people! Join our Discord
- Ticker
- CLGN
- Price
- 1.47
- Stock movement up
- +0.43 (22.01%)
- Company name
- Collplant Biotechnologies Ltd
- Exchange
- (NASDAQ ,
- Currency
- USD )
- Sector
- Healthcare >Biotechnology
- Market cap
- 30.52M
- Ent value
- 20.67M
- Price/Sales
- 46.95
- Price/Book
- 1.80
- Div yield
- -
- Div growth
- -
- Growth years
- -
- FCF payout
- -
- Trailing P/E
- -
- Forward P/E
- -
- PEG
- -
- EPS growth
- 105.54%
- 1 year return
- -51.07%
- 3 year return
- -36.94%
- 5 year return
- -23.44%
- 10 year return
- -
Last updated: 2025-09-12
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
DIVIDENDS
CLGN does not pay dividends or no data was received
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
VALUATION
Valuation Ratios
Loading...
Valuation Ratios data
| Trailing P/E | - |
| Price to OCF | - |
| Price to FCF | - |
| Price to EBITDA | - |
| EV to EBITDA | - |
Valuation (Sales/Book Value)
Loading...
Valuation (Sales/Book Value) data
| Price to Sales | 46.95 |
| Price to Book | 1.80 |
| EV to Sales | 31.80 |
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
FINANCIALS
Per share
Loading...
Per share data
| Current share count | 12.72M |
| EPS (TTM) | -1.52 |
| FCF per share (TTM) | -1.11 |
Income statement
Loading...
Income statement data
| Revenue (TTM) | 650.00K |
| Gross profit (TTM) | -1.76M |
| Operating income (TTM) | -18.34M |
| Net income (TTM) | -17.42M |
| EPS (TTM) | -1.52 |
| EPS (1y forward) | -0.04 |
Margins
Loading...
Margins data
| Gross margin (TTM) | -270.15% |
| Operating margin (TTM) | -2822.31% |
| Profit margin (TTM) | -2680.00% |
Balance Sheet
Loading...
Please create a free account or log in to access this chart
Balance Sheet data
| Cash | 15.37M |
| Net receivables | 431.00K |
| Total current assets | 16.50M |
| Goodwill | 0.00 |
| Intangible assets | 0.00 |
| Property, plant and equipment | 0.00 |
| Total assets | 22.44M |
| Accounts payable | 1.01M |
| Short/Current long term debt | 3.25M |
| Total current liabilities | 3.07M |
| Total liabilities | 5.52M |
| Shareholder's equity | 16.92M |
| Net tangible assets | 0.00 |
Cash flow
Loading...
Please create a free account or log in to access this chart
Cash flow data
| Operating cash flow (TTM) | -12.97M |
| Capital expenditures (TTM) | 653.00K |
| Free cash flow (TTM) | -12.77M |
| Dividends paid (TTM) | 0.00 |
Financial returns
Loading...
Please create a free account or log in to access this chart
Financial returns data
| Return on Equity | -102.97% |
| Return on Assets | -77.62% |
| Return on Invested Capital | -98.33% |
| Cash Return on Invested Capital | -72.09% |
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
STOCK INFORMATION
Stock chart
Loading...
Stock price data
| Open | 1.94 |
| Daily high | 2.56 |
| Daily low | 1.94 |
| Daily Volume | 108K |
| All-time high | 27.86 |
| 1y analyst estimate | 11.56 |
| Beta | 0.78 |
| EPS (TTM) | -1.52 |
| Dividend per share | - |
| Ex-div date | - |
| Next earnings date | 26 Nov 2025 |
Downside potential
Loading...
Downside potential data
| CLGN | S&P500 | |
| Current price drop from All-time high | -91.38% | -1.46% |
| Highest price drop | -95.15% | -56.47% |
| Date of highest drop | 7 Jul 2025 | 9 Mar 2009 |
| Avg drop from high | -71.28% | -10.99% |
| Avg time to new high | 910 days | 12 days |
| Max time to new high | 1820 days | 1805 days |
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
COMPANY DETAILS
Marketcap
30.52M
Marketcap category
Small-cap
Description
CollPlant Biotechnologies Ltd., a regenerative and aesthetic medicine company, focuses on three-dimensional (3D) bioprinting of tissues and organs, and medical aesthetics in the United States, Canada, Israel, Europe, and internationally. The company's products are based on its recombinant human collagen (rhCollagen) that is produced using its proprietary technology. It offers regenerative dermal and soft tissue fillers; 3D-bioprinted regenerative breast implants; VergenixSTR, a soft tissue matrix for the treatment of tendinopathy; and VergenixFG, a wound healing flowable gel for the treatment of chronic and acute wounds. The company also provides rhcollagen-based commercial bioink for regenerative medicine applications, such as Collink.3D 50L, a bioink in powder form; Collink.3D 90, an rhCollagen-based bioink solution for use in various 3D bioprinting applications; and Collink.3D 50, an rhCollagen-based bioink product. It has collaboration agreements with AbbVie; STEMCELL; the Advanced Regenerative Manufacturing Institute; Stratasys; and RegenMed Development Organization. The company was formerly known as CollPlant Holdings Ltd. and changed its name to CollPlant Biotechnologies Ltd. in June 2019. CollPlant Biotechnologies Ltd. was founded in 2004 and is headquartered in Rehovot, Israel.
Employees
57
Website
Investor relations
-
SEC filings
CEO
Yehiel Tal
Country
USA
City
Rehovot
Stock type
American depositary share
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
Loading...
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
UNDERSTAND THE BUSINESS
Loading...
COMPANY NEWS
Seeking AlphaPress releases
iO Charts is a Seeking Alpha partnerNext page